New research has found that Cannnabidiol is active against Gram-positive bacteria, including those responsible for many serious infections (such as Staphyloccocus aureus and Streptococcus pneumoniae), with potency similar to that of established antibiotics such as vancomycin or daptomycin.
The research is presented at ASM Microbe, the annual meeting of the American Society for Microbiology.
Cannabidiol, the main non-psychoactive chemical compound extracted from cannabis and hemp plants, has been approved by FDA for the treatment of a form of epilepsy, and is being investigated for a number of other medical conditions, including, anxiety, pain and inflammation. While there is limited data to suggest Cannabidiol can kill bacteria, the drug has not been thoroughly investigated for its potential as an antibiotic.
Work led by Dr Mark Blaskovich at The University of Queensland’s Institute for Molecular Bioscience’s Centre for Superbug Solutions, in collaboration with Botanix Pharmaceuticals Ltd, an early stage drug discovery company investigating topical uses of synthetic cannabidiol for a range of skin conditions, found that Cannabidiol was remarkably effective at killing a wide range of Gram-positive bacteria, including bacteria that have become resistant to other antibiotics, and did not lose effectiveness after extended treatment.
“Given cannabidiol’s documented anti-inflammatory effects, existing safety data in humans, and potential for varied delivery routes, it is a promising new antibiotic worth further investigation,” said Dr. Blaskovich. “The combination of inherent antimicrobial activity and potential to reduce damage caused by the inflammatory response to infections is particularly attractive.”
Importantly, the drug retained its activity against bacteria that have become highly resistant to other common antibiotics. Under extended exposure conditions that lead to resistance against vancomycin or daptomycin, Cannabidiol did not lose effectiveness. Cannabidiol was also effective at disrupting biofilms, a physical form of bacteria growth that leads to difficult-to-treat infections.
The project was co-funded by Botanix and Innovation Connections, an Australian government grant scheme to commercialize new products, processes and services. The paper will be presented on Sunday June 23rd from 11am-1 pm at the annual conference of the American Society for Microbiology, ASM Microbe 2019, at the Moscone Convention Center in San Francisco.
Learn more: Cannabidiol is a Powerful New Antibiotic
The Latest on: Cannnabidiol
via Google News
The Latest on: Cannnabidiol
- Cannabidiol (CBD) Market Will Predicted at 33.5% CAGR to Reach 2288.7 Million US$ by the End of 2025 : ENDOCA, CBD American Shaman, Gaia Botanicalson July 3, 2019 at 11:38 am
According to a new report published by QY Research, Titled “Global Cannabidiol (CBD) Industry Research Report, Growth Trends and Competitive Analysis 2019-2025” by Company Profile Rising investments ... […]
- Global Cannabidiol (CBD) Market is expected to reach to USD 17,345.80 Million by 2026 : Fior Marketson July 3, 2019 at 9:05 am
Ney Jersey, July 03, 2019 (GLOBE NEWSWIRE) -- Fior Markets launched a study titled “Cannabidiol (CBD) Market by Product (Food Grade, Therapeutic Grade), Application (Neurogenerative Disorder ... […]
- Cannabidiol (CBD) Market 2019- Global Industry Analysis, By Key Players, Segmentation, Trends and Forecast By 2025on July 3, 2019 at 3:31 am
Cannabidiol (CBD) is a naturally occurring compound that is extracted from cannabis plants. It is a 21-carbon terpenophenolic compound which is formed following decarboxylation from a ... […]
- Global Cannabidiol (CBD) Market 2019 Trends, Market Share, Industry Size, Growth, Sales, Opportunities, Analysis and Forecast To 2025on July 3, 2019 at 2:11 am
Summary: A new market study, titled “Discover Global Cannabidiol (CBD) Market Upcoming Trends, Growth Drivers and Challenges” has been featured on WiseGuyReports. Cannabidiol (CBD) is a naturally ... […]
- Cannabidiol (CBD) Market 2019 Global Industry Demand, Sales, Suppliers, Analysis and Forecasts to 2024on July 1, 2019 at 5:22 pm
(MENAFN - iCrowdNewsWire) Scope of the Report: This report focuses on the Cannabidiol (CBD) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and ... […]
- Rumson cannabidiol brand CBD For Life acquired by iAnthus for $10.4 millionon July 1, 2019 at 10:55 am
Multi-state cannabis operator iAnthus Capital Holdings Inc. closed a previously announced agreement to acquire CBD For Life, based in Rumson, for $10.4 million in stock and cash on June 30. ... […]
- Lynne Gray: Suddenly, cannabidiol is everywhere and in everythingon June 30, 2019 at 10:03 pm
A year ago, I found myself in ‘Cosmic Coffee’ in Burlington, Vermont. Amongst the myriad of choices, I was surprised to find a “cannabis coffee” with the opportunity to add a shot of “CBD oil” to my ... […]
- CBD: Is cannabidiol a miracle cure or fad?on June 27, 2019 at 5:47 pm
A cannabis-based drug may soon be available to treat extreme forms of childhood epilepsy. Before sales begin, the US Drug Enforcement Agency (DEA) must reclassify the cannabis compound CBD as having ... […]
- Cannabidiol for seniors? Maybe.on June 27, 2019 at 4:22 pm
Many of those in healthcare, including myself, may be fairly rigid when it comes to medications and treatment: Show us the evidence of efficacy and the data around the pros and cons, including side ... […]
- Cannabidiol: What It Does, Where To Find It And The Legislative Battle To Legalize Iton June 26, 2019 at 12:56 pm
Both compounds interact with cannabinoid receptors in the body’s endocannabinoid system, which are neurotransmitters. Sources: U.S. Department of Agriculture, Texas Department of Public Safety ... […]
via Bing News